Monica Flores-Muñoz

Dr. Monica Flores-Muñoz

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Jocelyn Carolina Pérez-LaraJocelyn Carolina Pérez-Lara
Jocelyn Carolina Pérez-Lara
EEEnrique Espinosa
Enrique Espinosa
LSLeopoldo Santos-Argumedo
Leopoldo Santos-Argumedo
HRHECTOR ROMERO
HECTOR ROMERO
GHGabriela Lopez Herrera
Gabriela Lopez Herrera
JRJuan Carlos Rodríguez-Alba
Juan Carlos Rodríguez-Alba
CD38 is a transmembrane glycoprotein expressed by T-cells. It has been reported that patients with systemic lupus erythematosus (SLE) showed increased CD38+CD25+ T-cells correlating with immune activation and clinical signs. Contrariwise, CD38 deficiency in murine models has shown enhanced autoimmunity development. Recent studies have suggested that CD38+ regulatory T-cells are more suppressive than CD38− regulatory T-cells. Thus, we have suggested that CD38 overexpression in SLE patients could play a role in regulating immune activation cells instead of enhancing it. This study found a correlation between CD38 with FoxP3 expression and immunosuppressive molecules (CD69, IL-10, CTLA-4, and PD-1) in T-cells from lupus-prone mice (B6.MRL-Faslpr/J). Additionally, B6.MRL-Faslpr/J mice showed a decreased proportion of CD38+ Treg cells regarding wild-type mice (WT). Furthermore, Regulatory T-Cells (Treg cells) from CD38-/- mice showed impairment in expressing immunosuppressive molecules and proliferation after stimulation through the T-cell receptor (TCR). Finally, we demonstrated an increased ratio of IFN-γ/IL-10 secretion in CD38-/- splenocytes stimulated with anti-CD3 compared with the WT. Altogether, our data suggest that CD38 represents an element in maintaining activated and proliferative Treg cells. Consequently, CD38 could have a crucial role in immune tolerance, preventing SLE development through Treg cells.

1 October 2019 in Phytomedicine
Verified
Journal Article
Closed access
CJClaudia Juárez-Portilla
Claudia Juárez-Portilla
TOTatiana Olivares-Bañuelos
Tatiana Olivares-Bañuelos
TMTania Molina-Jiménez
Tania Molina-Jiménez
JSJosé Armando Sánchez-Salcedo
José Armando Sánchez-Salcedo
DMDiana I. Del Moral
Diana I. Del Moral
RZRossana C Zepeda
Rossana C Zepeda

10 April 2024 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
DÁDiana V. Ávila-Martínez
Diana V. Ávila-Martínez
WMWendy K. Mixtega-Ruiz
Wendy K. Mixtega-Ruiz
JHJosé M. Hurtado-Capetillo
José M. Hurtado-Capetillo
OLOscar Lopez
Oscar Lopez
MFMonica Flores-Muñoz
Monica Flores-Muñoz
The renin-angiotensin system (RAS) is an important cascade of enzymes and peptides that regulates blood pressure, volume, and electrolytes. Within this complex system of reactions, its counter-regulatory axis has attracted attention, which has been associated with the pathophysiology of inflammatory and fibrotic diseases. This review article analyzes the impact of different components of the counter-regulatory axis of the RAS on different pathologies. Of these peptides, Angiotensin-(1–7), angiotensin-(1–9) and alamandine have been evaluated in a wide variety of in vitro and in vivo studies, where not only they counteract the actions of the classical axis, but also exhibit independent anti-inflammatory and fibrotic actions when binding to specific receptors, mainly in heart, kidney, and lung. Other functional peptides are also addressed, which despite no reports associated with inflammation and fibrosis to date were found, they could represent a potential target of study. Furthermore, the association of agonists of the counter-regulatory axis is analyzed, highlighting their contribution to the modulation of the inflammatory response counteracting the development of fibrotic events. This article shows an overview of the importance of the RAS in the resolution of inflammatory and fibrotic diseases, offering an understanding of the individual components as potential treatments.

8 June 2025 in Addiction Biology
Verified
Journal Article
Open access
LVLeonardo Vázquez‐Morales
Leonardo Vázquez‐Morales
GAGisela Aguirre
Gisela Aguirre
TMTania Molina‐Jiménez
Tania Molina‐Jiménez
RZRossana C Zepeda
Rossana C Zepeda
ÓLÓscar López‐Franco
Óscar López‐Franco
CJClaudia Juárez‐Portilla
Claudia Juárez‐Portilla
Substance use disorder constitutes a global health challenge. Preclinical investigations into addiction heavily rely on animal models to explore the underlying biological mechanisms of addictive disorders, with a particular emphasis on understanding the etiological factors influencing drug intake. Exploring sex differences across various phases of addiction has revealed a heightened vulnerability in females. This study systematically reviews the impact of ovarian hormones on the consumption of psychoactive substances in rodents, adhering to the PRISMA 2009 protocol. Our findings underscore the significant role of ovarian hormones, particularly oestrogen, in augmenting drug consumption among female rodents. Notably, with heroin, it was observed that progesterone, rather than oestrogen, facilitated increased consumption in female rodents. The susceptibility to addiction influenced by oestrogen is accentuated across distinct phases, and the molecular mechanisms form a complex interplay that significantly influences addictive behaviours. By bringing together these findings, we aim to establish a strong foundation for future studies. This work may guide clinical investigations in developing more effective prevention or treatment strategies that address the unique vulnerabilities of females to substance use disorders.

16 September 2020 in Journal of Nutrition and Metabolism
Verified
Journal Article
Open access
PDF file
SRSergio Cuéllar Rufino
Sergio Cuéllar Rufino
RZRossana C Zepeda
Rossana C Zepeda
MFMonica Flores-Muñoz
Monica Flores-Muñoz
SISantiago-Roque Isela
Santiago-Roque Isela
OAOmar Arroyo-Helguera
Omar Arroyo-Helguera
Overweight and obesity are defined as excessive and abnormal fat accumulation that is harmful to health. This study analyzes the effect of different concentrations of the lugol solution (molecular iodine dissolved in potassium iodide) on lipolysis in cultured 3T3-L1-differentiated adipocytes. The mature adipocytes were treated with doses from 1 to 100 µm of lugol for 0.5, 6, and 24 h. The results showed that mature adipocytes exposed to lugol decrease their viability and increase caspase-3 activity with a lethal dose (LD50) of 473 µm. In mature adipocytes, lugol decreased the total intracellular lipid content, being significant at doses of 10 and 100 µm after 6 and 24 h of treatment (P<0.01), and the accumulation of intracellular triglycerides decreased after 24 h of exposure to lugol (P<0.05). Lugol treatment significantly increases the release of glycerol to the culture medium (P<0.05). The levels of adipocyte-specific transcription factors C/EBP-αwere downregulated and PPAR-γupregulated after 30 min with lugol. These results indicate a lipolytic effect of lugol dependent on PPAR-γand C/EBP-αexpression in mature 3T3-L1 adipocytes.

1 March 2022 in Endocrinología, Diabetes y Nutrición
Verified
Journal Article
Closed access
PVPaulina E. Viveros-Watty
Paulina E. Viveros-Watty
OLOscar López-Franco
Oscar López-Franco
RZRossana C. Zepeda
Rossana C. Zepeda
GAGisela Aguirre
Gisela Aguirre
JRJuan C. Rodríguez-Alba
Juan C. Rodríguez-Alba
MFMonica Flores-Muñoz
Monica Flores-Muñoz